The Kynurenine Pathway in Tuberculosis: Focus on Immunometabolic Regulation, Compartment-Specific Biology, and Therapeutic Potential. [PDF]
Life (Basel)Stasiak P +5 more
europepmc +1 more source
Investigating the Mechanism of Resistance to IDO1 Enzyme Inhibitor Treatment in Human Glioblastoma
Glioblastoma (GBM) is the most common and most aggressive form of adult cancer in the central nervous system, with GBM accounting for the majority of all malignant brain tumors.
Hatton, Kyla Shivakumar
core +1 more source
IDO1 Silencing Enhances Cisplatin Sensitivity in Gastric Cancer Cells via Modulation of Apoptosis and Oxidative Stress. [PDF]
Curr Issues Mol BiolTaghavi Pourianazar N +2 more
europepmc +1 more source
Differentiation therapy targeting indoleamine 2,3-dioxygenase 1 in glioblastoma cells <i>in vitro</i>. [PDF]
Mol Clin OncolNishide K +5 more
europepmc +1 more source
Editorial Comment on "Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression": Rethinking the Tryptophan-Kynurenine Pathway in Urological Cancer Immunotherapy. [PDF]
Int J UrolAlmulla AF, Zhang Y, Maes M.
europepmc +1 more source
Targeting the AHR-IDO1-kynurenine pathway in TREM2<sup>+</sup> macrophages restores antitumor immunity in thyroid cancer. [PDF]
Front ImmunolLe F, Huang X, Jiang Y, Lv S, Chen Y.
europepmc +1 more source
Lipophilic Ligand Efficiency-Monitored Discovery of Potent, Achiral, and Bioavailable Apo-IDO1 Inhibitors. [PDF]
ACS Med Chem LettKazmierski WM +15 more
europepmc +1 more source